MTOR and breast cancer: One study observed that miR-214 promotes breast cancer progression by impairing the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signal transduction (PI3K/Akt/mTOR) pathway [29].